Primary treatment of chronic pulmonary aspergillosis with weekly liposomal amphotericin B: A case report from Uganda
Chronic pulmonary aspergillosis (CPA) treatment in Africa remains unexplored. We present a 23-year-old Ugandan male, previously treated thrice for pulmonary tuberculosis, developing CPA. Imaging showed lung fibrosis, bronchiectasis, and a fungal ball. He received weekly 600mg (10mg/kg) of liposomal...
Saved in:
| Main Authors: | Winnie Kibone, Felix Bongomin, David W. Denning, David B. Meya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Medical Mycology Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221175392400040X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01) -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
by: Youssef Gargani, et al.
Published: (2011-01-01) -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
by: Youssef Gargani, et al.
Published: (2011-01-01) -
Hematemesis Leading to Diagnosis of Pulmonary Aspergillosis
by: Mazin Mohammed Al-Mubasher, et al.
Published: (2025-01-01) -
Prophylactic use of liposomal amphotericin B in children and adolescents undergoing allogeneic hematopoietic cell transplantation: A 10-years single center experience
by: Laura G.Y. Rotte, et al.
Published: (2024-12-01)